$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
肝脏毒属性是直肠癌患者需要着重注意的事项之一
2025-10-19 11:44:20
Check Details
瑞格非尼诱导的转移性胃肠道间质瘤患者重度肝损伤:免疫抑制剂可以改善
2025-10-19 11:44:20
Check Details
服用瑞格非尼需要定期检测肝肾功能、血常规
2025-10-19 11:44:20
Check Details
瑞格非尼治疗经治结直肠癌患者的预后临床因素:对临床管理的影响
2025-10-19 11:44:20
Check Details
瑞格非尼+支架植入治疗伴重度气道狭窄的重症肺腺癌
2025-10-19 11:44:20
Check Details
经治结直肠癌患者服用瑞格非尼治疗的预后临床因素:对临床管理的影响
2025-10-19 11:44:20
Check Details
瑞格非尼服用期间,定期检测肝肾功能
2025-10-19 11:44:20
Check Details
瑞格非尼在日本实体瘤患者中的I期安全性及疗效研究
2025-10-19 11:44:20
Check Details
难治性转移性结直肠癌的真实世界治疗模式和结果
2025-10-19 11:44:20
Check Details
瑞格非尼成功治疗神经纤维瘤-胃肠道间质瘤
2025-10-19 11:44:20
Check Details
托法替尼治疗溃疡性结肠炎患者
2025-10-19 11:44:20
Check Details
曲美替尼+达拉非尼+化疗治疗BRAF V600E转移性结肠腺癌
2025-10-19 11:44:20
Check Details
1
2
...
1587
1588
1589
1590
1591
1592
1593
...
4150
4151
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Alectinib for ALK-Positive Lung Cancer: Efficacy, Side Effects & Clinical Outlook
2
Which Generation TKI Is Repotrectinib? Professional Analysis of Next-Gen ROS1 Inhibitor Classification and Clinical Features
3
Dietary Guide During Goserelin Treatment: Scientific Nutrition Management to Alleviate Side Effects and Improve Quality of Life.
4
CYP26A1 Gene Emerges as New Target for Colorectal Cancer Treatment! Folate Metabolism Research Brings Hope for Immunotherapy.
5
Precision Breakthrough: Inavolisib Redefines Survival in PIK3CA-Mutant Breast Cancer
6
Optimal Regorafenib (Stivarga) Administration Guide: Low-Fat Diet, Fixed Timing, and Dose Escalation Strategies
7
Guidelines for the timing, method, and precautions of taking Erlotinib (Trokai).
8
Important Information for Safe Use of Ibrutinib
9
Comprehensive description of palbociclib
10
Pralsetinib: The RET Precision-Targeted Therapy That Rewrites the Treatment History of Rare Cancers
11
Detailed introduction to the instruction manual of revumenib
12
Ryeqo (Relugolix compound tablets) - long-term treatment for uterine fibroids